PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis J Hou, R Zhao, W Xia, CW Chang, Y You, JM Hsu, L Nie, Y Chen, ... Nature cell biology 22 (10), 1264-1275, 2020 | 719 | 2020 |
Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth Y Yang, CW Li, LC Chan, Y Wei, JM Hsu, W Xia, JH Cha, J Hou, JL Hsu, ... Cell research 28 (8), 862-864, 2018 | 443 | 2018 |
Palmitoylation stabilizes PD-L1 to promote breast tumor growth YI Yang, JM Hsu, L Sun, LC Chan, CW Li, JL Hsu, Y Wei, W Xia, J Hou, ... Cell research 29 (1), 83-86, 2019 | 219 | 2019 |
Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity J Hou, JM Hsu, MC Hung Molecular cell 81 (22), 4579-4590, 2021 | 207 | 2021 |
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer L Nie, Y Wei, F Zhang, YH Hsu, LC Chan, W Xia, B Ke, C Zhu, R Deng, ... Nature communications 10 (1), 5114, 2019 | 88 | 2019 |
Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer B Shao, CW Li, SO Lim, L Sun, YJ Lai, J Hou, C Liu, CW Chang, Y Qiu, ... American journal of cancer research 8 (9), 1837, 2018 | 73 | 2018 |
Targeting PKCδ as a therapeutic strategy against heterogeneous mechanisms of EGFR inhibitor resistance in EGFR-mutant lung cancer PC Lee, YF Fang, H Yamaguchi, WJ Wang, TC Chen, X Hong, B Ke, ... Cancer cell 34 (6), 954-969. e4, 2018 | 70 | 2018 |
Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR J Hou, X Li, C Li, L Sun, Y Zhao, J Zhao, S Meng Molecular oncology 9 (7), 1312-1323, 2015 | 67 | 2015 |
Cell membrane gp96 facilitates HER 2 dimerization and serves as a novel target in breast cancer X Li, L Sun, J Hou, M Gui, J Ying, H Zhao, N Lv, S Meng International Journal of Cancer 137 (3), 512-524, 2015 | 60 | 2015 |
PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer XK Yin, YL Wang, F Wang, WX Feng, SM Bai, WW Zhao, LL Feng, MB Wei, ... Oncogene 40 (7), 1375-1389, 2021 | 51 | 2021 |
Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer B Wu, X Chu, C Feng, J Hou, H Fan, N Liu, C Li, X Kong, X Ye, S Meng Cancer letters 359 (2), 325-334, 2015 | 38 | 2015 |
Interaction of toll-like receptors with the molecular chaperone Gp96 is essential for its activation of cytotoxic T lymphocyte response W Liu, M Chen, X Li, B Zhao, J Hou, H Zheng, L Qiu, Z Li, S Meng PLoS One 11 (5), e0155202, 2016 | 31 | 2016 |
A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes L Sun, Y Zhang, B Zhao, M Deng, J Liu, X Li, J Hou, M Gui, S Zhang, X Li, ... Protein & Cell 5 (4), 317-327, 2014 | 27 | 2014 |
Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma M Deng, J Hou, J Hu, S Wang, M Chen, L Chen, Y Ju, C Li, S Meng Cancer letters 383 (1), 62-72, 2016 | 26 | 2016 |
A novel dendrimeric peptide induces high level neutralizing antibodies against classical swine fever virus in rabbits GX Li, YJ Zhou, H Yu, L Li, YX Wang, W Tong, JW Hou, YZ Xu, JP Zhu, ... Veterinary microbiology 156 (1-2), 200-204, 2012 | 24 | 2012 |
Author Correction: PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis J Hou, R Zhao, W Xia, CW Chang, Y You, JM Hsu, L Nie Nature Cell Biology 22 (11), 1396-1397, 2020 | 22 | 2020 |
PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response LL Liu, J Hou, Y Xu, L Qin, W Liu, H Zhang, Y Li, M Chen, M Deng, B Zhao, ... PLoS One 15 (7), e0228302, 2020 | 20 | 2020 |
PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression X Chu, B Wu, H Fan, J Hou, J Hao, J Hu, B Wang, G Liu, C Li, S Meng Antiviral Research 127, 41-49, 2016 | 20 | 2016 |
Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models S Wang, CW Chang, J Huang, S Zeng, X Zhang, MC Hung, J Hou The Journal of Clinical Investigation 134 (1), 2024 | 18 | 2024 |
Chaperone gp96 mediates ER-α36 cell membrane expression J Hou, M Deng, X Li, W Liu, X Chu, J Wang, F Chen, S Meng Oncotarget 6 (31), 31857, 2015 | 18 | 2015 |